Lupin gets USFDA nod to market generic Sevelamer Carbonate tablets

The product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis, Lupin said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3a5bqwm
via IFTTT

0 comments:

Post a Comment